Page last updated: 2024-08-18

furan and rosiglitazone

furan has been researched along with rosiglitazone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, WM; Hou, W; Huang, MY; Lin, J; Sun, PH; Wang, F	1

Other Studies

2 other study(ies) available for furan and rosiglitazone

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
5-Benzylidene-3,4-dihalo-furan-2-one derivatives inhibit human leukemia cancer cells through suppression of NF-κB and GSK-3β. Anti-cancer agents in medicinal chemistry, 2015, Volume: 15, Issue:6 Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Furans; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HeLa Cells; HT29 Cells; Humans; Leukemia; Membrane Potential, Mitochondrial; NF-kappa B; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rosiglitazone; Thiazolidinediones; U937 Cells; Up-Regulation	2015

Article

Year

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

Chemical research in toxicology, 2010, Volume: 23, Issue:1

Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010

5-Benzylidene-3,4-dihalo-furan-2-one derivatives inhibit human leukemia cancer cells through suppression of NF-κB and GSK-3β.

Anti-cancer agents in medicinal chemistry, 2015, Volume: 15, Issue:6

Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Furans; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HeLa Cells; HT29 Cells; Humans; Leukemia; Membrane Potential, Mitochondrial; NF-kappa B; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rosiglitazone; Thiazolidinediones; U937 Cells; Up-Regulation

2015